Blog
RSS FeedPosted by Michael Wonder on 08 Jan 2022
CMS takes action to lower out of pocket Medicare Part D prescription drug costs
6 January 2022 - Today, the Centers for Medicare & Medicaid Services issued a proposed rule that would make updates to ...
Posted by Michael Wonder on 14 Dec 2021
Permanent telehealth to strengthen universal Medicare
13 December 2021 - The Australian Government is investing $308.6 million to strengthen Australia’s primary care health system, building on our ...
Posted by Michael Wonder on 24 Nov 2021
Califf, Biden’s pick to lead FDA, has millions invested in pharma and tech companies
23 November 2021 - Robert Califf, President Biden’s choice to lead the FDA, earned $2.7 million as an executive at ...
Posted by Michael Wonder on 23 Nov 2021
Medicare coverage of aducanumab — implications for state budgets
20 November 2021 - CMS is considering whether and under what circumstances Medicare will pay for aducanumab for Alzheimer’s disease. ...
Posted by Michael Wonder on 15 Nov 2021
It's time for Congress to get Medicare drug pricing reform right
15 November 2021 - After a three-year debate and delay in delivering patients much-needed relief from high out-of-pocket prescription drug costs, ...
Posted by Michael Wonder on 15 Nov 2021
Medicare premiums to jump in part due to pricey Alzheimer's drug
12 November 2021 - Seniors on Medicare will have to pay more than $20 more per month extra in premiums ...
Posted by Michael Wonder on 03 Nov 2021
Democrats revive drug pricing reform with a narrow set of proposed measures
2 November 2021 - On Tuesday 2 November, Senator Schumer announced that an agreement had been reached regarding lowering drug ...
Posted by Michael Wonder on 02 Nov 2021
Medicare to fund allied health case conferencing
1 November 2021 - New Medicare items will encourage eligible health providers to work together more closely to support the health ...
Posted by Michael Wonder on 26 Oct 2021
Cystic fibrosis medicine added to PHARMAC's options for investment list
27 October 2021 - PHARMAC has announced that Vertex’s triple combination modulator therapy, known in some countries as Trikafta, has ...
Posted by Michael Wonder on 24 Oct 2021
Patient and payer incentives to use patented brand name drugs vs authorised generic drugs in Medicare Part D
18 October 2021 - This cross-sectional study of Medicare formulary and pricing data for quarter 3 of 2020 found that most ...
Posted by Michael Wonder on 12 Oct 2021
European authorities launch HTA network
12 October 2021 - On 29 September, the heads of 19 European HTA authorities met to launch a network for strategic ...
Posted by Michael Wonder on 12 Oct 2021
NICE guidance on inclisiran should be reconsidered
12 October 2021 - Recommendation is premature without data on cardiovascular outcomes. ...
Posted by Michael Wonder on 07 Oct 2021
Ban on negotiating Medicare drug prices under pressure
7 October 2021 - Negotiating Medicare drug prices is a linchpin of President Joe Biden's ambitious health care agenda. ...
Posted by Michael Wonder on 05 Oct 2021
Medicare reverses course on decision to universally cover breakthrough medical devices for 4 years
4 October 2021 - In January 2021, in the waning days of the Trump Administration, the CMS finalised a rule ...
Posted by Michael Wonder on 20 Sep 2021
Medicare bulk billing rates at all time high
18 September 2021 - The latest Medicare data showing that almost nine out of 10 visits to the GP in 2020-21 ...